Clinical Trial Update: A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial investigating a novel oncolytic virus in combination with a PD-1 inhibitor for recurrent high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Novel Oncolytic Virus
• PD-1 inhibitor

Snippet

Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd | Conditions: High-grade Glioma | Phase 1 | Status: NOT_YET_RECRUITING